Nature Reviews Rheumatology Ревматология
Rituximab not superior to azathioprine for EGPA remission maintenance
Аннотация
Nature Reviews Rheumatology, Published online: 10 November 2026; doi:10.1038/s41584-026-01465-4 In the MAINRITSEG clinical trial, treatment with rituximab did not confer an advantage over azathioprine for the maintenance of remission in patients with eosinophilic granulomatosis with polyangiitis.